Health Sciences

Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online this week in AIDS.

Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells.

Aging does not appear to be a factor in poor sleep, a new study by Perelman School of Medicine at the University of Pennsylvania shows. In fact, subjective sleep quality seems to improve over a lifetime, with the fewest complaints coming from people in their 80s.

Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map — literally.

PHILADELPHIA — Four University of Pennsylvania faculty members are among this year’s Sloan Fellowship recipients. Since 1955, the Alfred P. Sloan Foundation has granted yearly fellowships to early-career scientists and scholars whose achievements and potential identify them the next generation of scientific leaders.

Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.

Injecting epilepsy patients with medication via an autoinjector -- similar to the EpiPens used to treat serious allergic reactions -- works more quickly to stop seizures than delivery of a drug via IV on board ambulances, according to a national study published today in the New England Journal of Medicine.

PHILADELPHIA — The University of Pennsylvania Graduate School of Education and Penn’s Perelman School of Medicine have launched Med Ed, a program to enhance the teaching abilities of those who teach America’s doctors. 

PHILADELPHIA -- Governor Tom Corbett’s FY2012-2013 Commonwealth budget proposes funding of $26.7 million for the University of Pennsylvania’s School of Veterinary Medicine, the only veterinary  school in Pennsylvania and one of only 28 veterinary schools in the United States.  The recommended funding is equal to the support received for FY2011-2012. 

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred.